Emmes, a global, full-service clinical research organization (CRO), appointed Peter Ronco chief executive officer. Ronco succeeds Christine Dingivan, who will serve as a senior advisor to executive chairman Sastry Chilukuri, and Emmes’ board of directors. Ronco is a global pharmaceutical executive with experience in a number of R&D leadership positions over more than two decades. He most recently served as senior vice president, global development at Johnson & Johnson, responsible for...